IBANDRONATE SODIUM
- Product NDC
- 51224-008
- 11-digit product format
- 512240008
- Labeler code
- 51224
- Product ID
- 51224-008_4d64c479-f90c-40a5-bfaf-c92f884b5133
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ibandronate Sodium
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- TAGI Pharma, Inc.
- Application
- ANDA204329
- Marketing category
- ANDA
- Marketing start
- 2022-06-30
- Marketing end
- 0000-00-00
- Substance
- IBANDRONATE SODIUM
- Active strength
- 3 mg/3mL
- Pharmacologic classes
- Bisphosphonate [EPC], Diphosphonates [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51224-008 | IBANDRONATE SODIUM INJECTION, SOLUTION [TAGI PHARMA, INC.] | 11 | Legacy NDC | 20250101_57970375-1b7f-43ec-b1f1-43b03168ac4a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51224-008-01 | 51224000801 | 1 SYRINGE, GLASS in 1 CARTON (51224-008-01) > 3 mL in 1 SYRINGE, GLASS | 2022-06-30 | 0000-00-00 | No | No | Current |